Bellevue Group AG - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$72,304,764
-50.6%
3,513,351
+12.8%
1.16%
-44.2%
Q2 2023$146,437,913
+12.9%
3,114,375
+0.8%
2.09%
+11.1%
Q1 2023$129,656,400
+14.5%
3,090,000
+4.1%
1.88%
+25.1%
Q4 2022$113,248,263
-2.7%
2,969,278
-0.0%
1.50%
-10.0%
Q3 2022$116,332,000
+21.1%
2,970,678
-0.1%
1.67%
+23.0%
Q2 2022$96,034,000
-4.9%
2,973,178
-2.6%
1.36%
+15.8%
Q1 2022$101,034,000
-26.4%
3,052,404
-5.4%
1.17%
-17.1%
Q4 2021$137,319,000
-3.4%
3,228,004
+0.6%
1.42%
-1.9%
Q3 2021$142,191,000
+5.9%
3,209,004
+35.7%
1.44%
+10.1%
Q2 2021$134,310,000
-0.9%
2,364,204
+30.6%
1.31%
-8.6%
Q1 2021$135,532,000
-0.1%
1,810,704
+15.5%
1.43%
-7.7%
Q4 2020$135,604,000
+40.5%
1,567,504
-0.8%
1.55%
+16.4%
Q3 2020$96,539,000
+64.0%
1,579,504
+11.6%
1.33%
+60.1%
Q2 2020$58,856,000
+44.5%
1,415,504
-0.2%
0.83%
+5.4%
Q1 2020$40,728,000
-56.9%
1,418,104
+8.3%
0.79%
-47.3%
Q4 2019$94,486,000
-48.3%
1,308,854
+0.4%
1.50%
-56.0%
Q3 2019$182,869,000
-24.4%
1,303,504
-1.4%
3.40%
-17.7%
Q2 2019$241,935,000
+9230.3%
1,321,404
+8006.8%
4.13%
+2788.8%
Q1 2019$2,593,000
+155.5%
16,300
+53.8%
0.14%
+113.4%
Q4 2018$1,015,000
-35.8%
10,600
-5.4%
0.07%
-33.0%
Q3 2018$1,582,000
-16.5%
11,200
-7.4%
0.10%
-37.9%
Q2 2018$1,894,000
-5.5%
12,100
-2.8%
0.16%
-19.1%
Q1 2018$2,005,000
-3.8%
12,450
-1.6%
0.20%
-8.7%
Q4 2017$2,084,00012,6500.22%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders